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ABSTRACT 
 The structural organization of cells and their associated extracellular matrix 
(ECM) is critical to overall tissue function. Recapitulating the complex, highly organized 
structure of a target tissue is a key to achieve the unique functional characteristics of 
native tissue. However, achieving this goal requires a system in which substrate 
physicochemical properties such as modulus, topology and surface chemistry can be 
modulated. Here, we developed a cell sheet-based harvest and transfer system that can 
rapidly produce patterned 2D cell sheets in any physiologically relevant size and shape 
for various cell types. We further show that these cell sheets can be stacked one on top of 
the other with high cell viability while preserving the patterns, and that they remain 
sufficiently intact in vivo to allow neovascularization. We can thus use this system to 
mimic both the 2D and 3D structure of native tissue structure. A further advantage of our 
system is its substrate modulus tuning capability, which allows us to provide an optimal 
biomechanical environment for the differentiation and phenotypic stabilization of specific 
cell types. Because hydrogels theoretically have no limit in 2D shape and size, this 
system is scalable for producing quality controlled multiple cell sheets in a short period 
of time. Our model should also aid in understanding the mechanisms that underlie cell-
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cell and cell-ECM communication in 3D environments, which will be imperative to 
improving engineered tissue design. We thus ultimately envision that our system could 
allow the rapid fabrication of functionalized three dimensional thick tissues from multiple 
stacks of cell sheets derived from autologous cells, which would be an important step 
forward in both tissue modeling and regenerative medicine in general. Finally, this 
system can also potentially serve as a powerful model to study in vivo tissue formation 
and growth as well as cancer cell behavior. 
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Chapter 1. Motivation 
 
 
 
1.1. The need for a novel cell-based tissue engineered approach to develop immediately 
implantable and integrating three-dimensional (3D) thick tissue 
 
1.1.1. General Significance:  
Tissue engineering is a multi-interdisciplinary field in which a combination of state-of-
the-art biology, medicine, and engineering is used to improve the health and quality of 
life by restoring, maintaining, or enhancing tissue and organ function. Today, numerous 
medical needs require tissue engineering solutions. For example, approximately one 
million Americans benefit from an organ or tissue transplant each year, as of May 2014 
there were approximately 124,000 people on the waiting list for donor organs, a large 
number of whom are not expected to get an organ transplant in time [1]. A significant 
portion of this need lies in the treatment of cardiovascular disease (CVD), which is the 
number one cause of death both in the US and globally. CVD was responsible for 17.3 
million deaths in US in 2008 (representing 30% of all global deaths) and is projected to 
account for 23.6 million deaths in the US by 2030 [2]. Because of the lack of organ 
donors, cardiovascular diseases often need tissue engineered alternative solutions to 
restore diseased tissues or organ function. While growing an intact heart remains well 
beyond the current state of the art in tissue engineering, a few constructs have been 
successful in supplying nutrients by diffusion. Still, developing a viable thick tissue 
implant that accurately replicates the native three-dimensional cell-extracellular matrix 
integrated microstructure and vascular network for nutrient supply and gas exchange 
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remains as a major challenge [3].  
 
1.1.2. Conventional Biomaterial Based Scaffolds for 3D Tissue Development: 
The development of engineered tissues has a long history. One of the earliest tissue 
engineering strategies was to seed a biocompatible synthetic scaffold with vascular (or 
other) cells. Depending on the intended usage, biodegradable synthetic materials such as 
poly(L-lactic acid) (PLLA), poly(glycolic acid) (PGA), poly(ethylene glycol) (PEG), 
polycaprolactones, polyorthoesters, polyanhydrides and polycarbonates have been 
characterized and used as scaffold materials [4][5][6]. Most synthetic scaffolds have a 
porous sponge structure (60% to 90% porosity), with varying pore diameter (0.7µm -
465µm) or fibrous (0.3-4µm diameter) (Figure 1.1-e,h) [6]. These synthetic materials 
suffered from the major disadvantage of not being able to control cell-to-biomaterial and 
cell-to-cell interaction, and as a result they have not been further developed. 
Although subsequent scaffold fabrication techniques, such as electrospinning, 
woven mesh and solvent casting, freeze drying, phase inversion, fiber bonding, melt-
based technologies, and high-pressure-based methods were more successful in mimicking 
the structural characteristics of ECM, biological degradation of synthetic biomaterials 
was found to release acidic by-products, that adversely affected cell growth and also 
elicited an undesirable inflammatory response [7][8]. These inadequacies drove the 
development of naturally derived materials such as alginate and chitosan. These scaffolds 
are biocompatible and easily processed into a hydrogel type scaffold, but their application 
has been limited due to poor mechanical strength (Figure 1.1-d) [9]. 
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To more closely mimic mechanical and chemical characteristics of natural ECM, 
single, purified ECM components such as collagen or fibronectin have been fabricated 
into scaffolds that are potentially less immunogenic and have a similar structure to native 
ECM [10]. In order to achieve sufficient tensile strengths applicable for most soft tissues 
(e.g. muscle: 11-13 kPa for healthy tissue [11]), the concentration of type I collagen, a 
major determinant of soft tissue mechanical properties, must be greater than 1.0mg/ml 
[12]. However, high concentrated (≥1.0mg/ml) and randomly oriented collagen scaffolds 
were found to interfere with cell ingrowth [13]. Furthermore, purely collagen-based 
scaffolds were unable to mimic the mechanical behavior of natural ECM, which contains 
numerous non-collagenous components such as proteoglycans, glycosaminoglycans, and 
elastic fibers. Therefore, a simplified scaffold model cannot accurately mimic the 
diversity of components and the resulting complex organization of the ECM and 
associated structural and mechanical properties regulating cellular behavior (Figure 1.1-
a,b) [12][14]. 
 
The most recent advances have involved the use of hydrogel scaffolds containing 
genetically engineered multifunctional peptides, which allow far better control over both 
the structural properties and biochemical characteristics. Depending on the amino acid 
sequence, the same set of amino acids can create a virtually unlimited range of protein 
materials with various structures [15][16]. DNA is also increasingly being explored as a 
hydrogel scaffold building block. Single-stranded DNA molecules can be self-assembled 
into predictable conformations due to pre-arranged specific base pairing sequences 
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[17][18]. However, these self-assembled hydrogel scaffolds still show poor mechanical 
properties and suffer the further disadvantage of generating an immunogenic response 
from the scaffold itself or degradation by-products [19][20]. Finally, decellularized native 
tissue scaffolds have been proposed as the alternative that should provide the closest 
structural similarity of native ECM, but it has also been noted that the decellularization 
process could change chemical and mechanical characteristics of ECM, leaving the 
potential for foreign body reaction and pathogen transmission [21][22].  
 
1.2. Design considerations and challenges for viable 3D engineered tissue development 
1.2.1. Recapitulation of native ECM structure and composition 
Native ECMs are 3D networks composed of various protein fibrils and fibers interwoven 
within a hydrated network of glycosaminoglycan chains whose inherent mechanical and 
biochemical stimuli provides a growth environment for the overlying cells [23]. This 3D 
structure means that engineered tissue constructed in 2D settings cannot replicate natural 
characteristics of cell sheets and their ECM [24].  
Although various pure or synthetic peptide and DNA-based biomaterials can 
mimic certain characteristics of natural ECM, such as fiber orientation, diameter, 
substrate stiffness, and susceptibility of cell-triggered proteolytic remodeling, these 
materials have not yet been successful in achieving complex, cell-customized 3D micro-
environments that modulate mechanical and chemical bi-directional communication 
between cell and ECM [22]. Because cells in native tissue dynamically remodel ECM 
according to environmental cues, creating an environment that is cell self-modifiable and 
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communicable with the overlying cells is critical for cell survival and proper function in 
3D engineered tissue constructs. In this sense, the ideal cell growth environment should 
consist of cell self-secreted ECM with minimal or no artificial materials [24][25]. 
 
1.2.2. ECs and Vasculogenesis in biomaterials:  
Another critical element for successful living 3D tissue construction is vascularization. 
Endothelialized biomaterials are formed by seeding endothelial cells (ECs) prior to 
implantation or by relying on the infiltration of the host’s vasculature into the material 
[26]. Vascular structure will be dictated by scaffold pore size and density. Most existing 
scaffolds have either multi-directional random fibrillar networks with pre-determined 
pore size (i.e. synthetic, purified ECM materials) or uniformly patterned structures (i.e. 
peptide or DNA-based materials) [27]. However, they do not provide any directional 
guidance for vascularization except non-precise chemical cues from incorporated 
cytokines [28]. Hydrogels with pre-determined planar patterned channels have been made 
but not as a three-dimensionally interconnected native vasculature-like channel network 
[29][30]. A viable thick tissue consisting of cell self-assembled microenvironment, 
promoting bi-directional mechanical and biochemical communication with ECM and 
vascular network, has not yet been developed.  
ECs form the endothelium, a continuous monolayer inside vessel wall, that 
serves as a nonthrombogenic surface by expressing anti-coagulant and fibrinolytic 
molecules such as thrombomodulin, heparan sulphate, NO and prostacyclin (PGI2), and 
by secreting specific binding factors (i.e. ectonucleotidases) that hydrolyze ADP, a 
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platelet activator [31]. By secreting tissue plasminogen activator, urokinase, and their 
inhibitors, the endothelium also balances between the pro-coagulation and anti-
coagulation. Under the dynamic flow condition, the endothelium regulates the overall 
vessel tone through the release of endothelium-derived relaxing factor (EDRF) such as 
NO and PGI2 for vasodilation and the peptide endothelin for vasoconstriction, 
respectively [32][33][34]. When new blood vessels form, ECs play two important roles: 
vasculogenesis (the process of vessel formation at the early stage of development without 
pre-existing vascular structure) and angiogenesis (formation of new vessels by the 
sprouting of endothelial cells of pre-existing vessels) [35]. Early vascularization of 
implanted biomaterials is in many cases through angiogenesis due to the inflammatory 
response caused by vascular injury from the implantation procedure and the host’ foreign 
body reaction [36]. 
 
1.3. Cell sheet engineering as an alternative to conventional scaffold-based tissue 
engineering -in engineered blood vessel design.   
Tissue structure is directly related to its function [37][38][39]. For example, a skeletal 
muscle is a special organ in which its structure largely defines its function, namely 
regulation of muscle contraction. This is particularly true in the synchronized movements 
of myofibers, which contain multiple layers of myotubes, and where synchronized 
contraction in each unit called sarcomere is responsible for precise muscle contraction 
control [38]. Therefore, it is absolutely critical to accurately recapitulate this structural 
organization to produce a biologically functional engineered tissue. In order to 
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recapitulate native tissue structure over the length scales required for tissue function, one 
must control cell movement and cell-ECM interactions [40][41]. Ideally, substrate 
topology should provide directional guidance to induce desired cell migration and 
alignment. Biomechanical environment control such as surface modulus as well as the 
temporal and spatial profile of growth factors should allow the modulation of cell 
phenotype and proliferation, allowing us to achieve cell self-assembly on cell-secreted 
ECM only [41][42][43]. Whereas, conventional tissue engineering has attempted to 
control these physicochemical parameters individually [44][45][46], cell sheet 
technology should allow us to control some of these parameters simultaneously, as cells 
and cell-secreted ECM are integrated in the form of a sheet without any artificial 
materials [47][48][49]. Furthermore, patterning of cell sheets should be able to mimic 2D 
native structure of cell sheets in target tissues, and proper stacking according to the 
anatomy of the target tissue could reproduce complex 3D tissue structure. In this way, an 
engineered tissue constructed of self-assembled cell sheets should be able to acquire 
specific tissue function [49][50]. However, several issues remain to be solved in order to 
make cell sheet technology a practical tool. Cell sheet technology should be able to 
provide cell-type specific physicochemical growth environments to modulate cell 
behavior or even differentiation in order to have a fully functional cell sheet consists of 
ECM of the correct composition. Cell sheets must also display high cell viability when 
stacked, and it will be necessary to produce multiple cell sheets within a short period of 
time while still achieving quality control [51][52][53].  
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1.4. Controlling biomechanical environment to maintain native cell phenotypic 
characteristics in cell sheet culture 
Using different media and growth factor additions, numerous efforts have been made to 
recreate the chemical growth environment of native tissues to maintain native target cell 
phenotypic characteristics in vitro culture, More recently, however, it has been 
discovered that maintenance of the proper biomechanical environment such as substrate 
stiffness is equally critical [54]. However, current cell sheet technology uses tissue 
culture plastic or Polydimethylsiloxane (PDMS) that has a stiffness value in the MPa 
range, while optimal stiffness for most soft tissue is in kPa range (Table 2.1). For 
example, the stiffness range of native skeletal muscle is (10-13kPa). As a result, muscle 
cells grown long term (>30 days) on plastic surfaces not exhibit the native contractile 
phenotype critical for muscle function. Therefore, any cell sheet culture system should 
ideally incorporate a means to modulate substrate stiffness to accurately match that of 
native target tissue. 
 
1.5. Project approach: Development of a cell-sheet based thick tissue that recapitulates 
native target tissue structure and function  
We hypothesized that a novel enzyme-degradable polymer hydrogel based cell sheet 
harvest and transfer system should allow us to develop a biologically responsive 3D thick 
tissue. Instead of a top-down approach, we propose to first induce cells to create in vitro 
2D micro-environments in a cell sheet, i.e. cell and cell-secreted ECM integrated in the 
form of a sheet, and then stack individual cell sheets to create a 3D tissue. In this system, 
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cell sheets are grown on two modified natural polymers: Carboxymethyl cellulose (CMC) 
conjugated with tyramine (ty) (CMC-ty) and alginate (Al) conjugated with tyramine (Al-
ty), both of which are degradable by a specific protease (cellulase and alginate lyase, 
respectively) [55][56]. This degradable hydrogel platform should allow us to mimic an in 
vivo 2D micro-environment without any artificial influences from pre-defined scaffold 
microstructure, and the use of patterned surfaces should guide cells to recapitulate target 
tissue 2D alignment. Therefore, in this thesis, we propose systematic studies on 
enzymatically degradable versatile hydrogel platform for cell sheet engineering to 
develop immediately implantable 3D engineered tissue. We explored several key 
questions whose answers should lead to the ultimate development of these 3D engineered 
tissues: 1. Can we recreate or induce cells to create 2D self-assembled ECM micro-
environment without adding artificial materials? 2. Can these micro tissues be assembled 
into a macrostructure? 3. Can we recreate native biomechanical growth environments to 
maintain or induce native target cell phenotypic characteristics? 4. Can this 
microstructure be vascularized in vivo? 
 
Aim 1: We will develop an enzymatically degradable hydrogel system that recapitulates 
native 2D biomechanical micro-growth environment and use it to grow a cell sheet 
mimicking native target tissue characteristics. 
Two modified natural polymers, CMC-ty andAl-ty)will be used to fabricate hydrogel 
substrates by HorseRadish Peroxidase (HRP) crosslinking under the presence of H2O2 
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[55][56]. Both polymers can form hydrogels inert to mammalian cells and the polymer 
surface can be patterned using a mold. CMC-ty and Al-ty are degradable by cellulase and 
alginate lyase respectively. Furthermore, CMC-ty and Al-ty substrate stiffness can be 
controlled by either altering their concentration in solution prior to crosslinking or 
altering the extent of dehydration at given concentration.  
 
Aim 2: To test the hypothesis that the stiffness of the hydrogel platform is critical for 
proper cell phenotypic characteristics and behavior, we will evaluate the differentiation 
of C2C12 (mouse myoblast precursor) cell sheets grown on tissue culture plastic and 
hydrogel substrates having two different stiffnesses. 
Cells are sensitive to their micro growth environment, especially biomechanical 
environment (i.e. substrate stiffness) [57]. We will investigate how substrate stiffness 
affects C2C12 characteristics using two different metrics. The first metric we will use is 
ECM composition and cell sheet failure stress. To assess matrix composition, we will use 
collagen type-1 ELISA to assess the effects of substrate stiffness on collagen type-1 
secretion. We will then correlate the ELISA results with cell sheet failure stress because 
collagen type-1 concentration is known to be an important ECM determinant of structural 
rigidity. We will also confirm that collagen type-1 is directly associated with structural 
rigidity of cell sheets by measuring Young’s modulus before and after treating with type-
1 collagenase. The second metric we will use is differentiation efficacy, measured using 
q-PCR and immunofluorescence (IF) techniques. In these studies, we will monitors 
changes in skeletal muscle cell differentiation markers over time (i.e. myogenin, myosin 
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heavy change (MYHC)), as well as fusion index changes. We will confirm IF results with 
q-PCR. With both metrics, we will compare results obtained from sheets grown on tissue 
culture plastic (1000X stiffer than native tissue) with those grown on softer hydrogels 
having two stiffnesses, one similar to native skeletal muscle (10-13kPa) and the other 10 
fold less than that of native skeletal muscle.  
 
Aim 3: We hypothesize that mature cell sheets grown on these sacrificial hydrogel 
substrates may be released undamaged to create tissue sheet stacks, and that these 
sheets should therefore be immediately implantable. In these studies we will implant a 
3-cell sheet stacked patch under the subcutaneous space of nude mice for 25-30 days to 
observe whether the implant can survive, recruit blood vessels and proliferate.  
When newly formed tissue grows, it requires nutrition and gas exchange. If diffusion is 
the only way to deliver nutrition and oxygen, core starts to suffer from necrosis when the 
tissue grows more than 400µm thickness [58]. To survive, any newly-introduced tissue 
thicker than 400µm must recruits new blood vessel. In these studies, we will take 
advantage of the fact that individual cells express proliferation markers if sufficient 
nutrition and oxygen supply are maintained. We will also harvest the implants (n=9) and 
investigate the presence of blood vessels. Target markers will be CD31/PECAM-1 
(endothelial cells), Lectin (vessel lumen), H-2Kk (not present in cells from the 
immunodeficiency nude mouse hosts), TER-119 (red blood cells) and proliferation 
marker (Ki-67). We will use immunofluorescent (IF) staining techniques to detect these 
markers.  
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Figure 1.1 Scanning electron microscope figures of various biomaterials; a. Collagen b. 
Fibrin, c. Decellularized matrix, d. Silk fibrion, e. SPCL (a blend of starch with 
polycaprolactone), f. Matrigel, g. PEG, and h. PLGA [59] 
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Figure 1.2 Self-assembled scaffold; A. DNA based scaffold with double crossover motif 
[105], B. IKVAV-containing peptide scaffold [16] 
 
 
 
 
Figure 1.3 Effects of random porous scaffold structure on ECs characteristics [3] 
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Figure 1.4 Illustration of skeletal muscle structural organization; Step by step illustration 
of detailed muscle structure and magnified view of single myofiber [60] 
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Table 1.1 tissue type and their native Young’s modulus (stiffness) 
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Chapter 2: Aim 1 
2.1. Motivation 
Accurate re-creation of the in vivo microenvironment, including the biomechanical 
aspects, is critical to induce proper cell phenotypic characteristics and, ultimately, thick 
tissue growth in vitro. In this aim, we describe the development of an enzymatically 
degradable hydrogel platform system that enable us to culture patterned cell sheets and 
stack cell sheets without interfering with individual cell sheet patterning and cell viability. 
We show that both CMC-ty and Al-ty can form hydrogel substrates by HRP reaction 
under the presence of H2O2. Furthermore, cell sheets grown degradation on either 
substrate to the substrate’s specific protease, cellulose and alginate lyase respectively, are 
released through degradation of the substrate without any effect on cell viability. We also 
show substrate stiffness tuning capability in this system that allows us to produce 
substrates that match to the stiffness of native target tissue. We hypothesize that 
stiffness tuned substrates will elicit proper cell response and behavior that 
recapitulate native tissue characteristics.  
 
2.2. Methods 
We chose a hydrogel substrate system to generate either patterned or non-patterned cell 
sheets because hydrogels can be easily formed with topological patterns, surface-cell 
interactions can be controlled through protein adsorption, and surface modulus can be 
tuned by changing the pre-gel solution concentration. CMC-ty and Al-ty hydrogels were 
chosen because they are degradable by their matching enzymes, cellulase and alginate 
lyase respectively, with the resultant release of the overlaying cell sheets [55][56]. In 
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experiments where cell sheets were stacked, we developed patterned hydrogel film 
substrates consisting of the same type of hydrogel.  
  
2.2.1. Development of Modified Enzyme Degradable Natural Polymer  
Reagents:  
Carboxymethyl cellulose (CMC) sodium salt (C4888), horseradish peroxidase (HRP) 
(P2088), hydrogen peroxidase solution (H3140), 1-Hydroxybenzotriazole hydrate (HOBt) 
(54804), tyramine hydrochloride (T2879), alginic acid sodium salt (A0682), 2-(N-
Morpholino)ethanesulfonic acid (MES) monohydrate (69889), N-(3-
Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC) (E1769) were 
purchased from Sigma Aldrich (St. Louis). N-hydroxysuccinimide (NHS) was purchased 
from Acros organics.  
 
Carboxymethyl cellulose (CMC) modification: 
0.5mM MES buffer was prepared and adjusted to pH 6.0. CMC-Na and tyramine 
hydrochloride were dissolved and stirred overnight. NHS, HOBt, and EDC were added 
and stirred for another 24 hours at room temperature to form CMC-tyramine conjugate 
(CMC-ty) (Figure 2.1-a). The polymer solution was dialyzed using 20,000 MW cut-off 
dialysis membrane (Thermo Scientific) for 48 hours, lyophilized using VirTis lyophilizer 
for 48 hours, and stored at -20°C until further use.  
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Alginate modification: 
1mM MES buffer was prepared and adjusted to pH 6.0. Alginic acid was dissolved in 
MES buffer overnight. NHS and EDC were added and stirred for 3 hours at room 
temperature. Tyramine hydrochloride was then added and stirred 24 hours to form an 
alginate-tyramine conjugate (Al-ty) (Figure 2.1-b). The polymer solution was dialyzed in 
a 20,000 MW cut-off dialysis membrane (Thermo Scientific) for 48 hours, lyophilized, 
and stored at -20°C until further use.  
 
Hydrogel formation: 
CMC-ty and Al-ty were dissolved in Krebs Ringer HEPES-buffered (KRH, pH 7.4) 
solution 1-4% w/v ratio (i.e. 0.1g in 10ml) to prepare the hydrogel solution. CMC-ty and 
Al-ty solutions were filtered using a 5µm and 1µm filter, respectively before gelation, 
and the resultant solutions were stored at 4°C for further use. To induce gelation, 
solutions of CMC-ty or Al-ty, HRP, and H2O2 were mixed with a 50:3:10 volume ratio, 
respectively. Due to batch-to-batch variation in the number of tyramines incorporated 
into cellulose or alginate, the mixing ratio was adjusted by varying the HRP volume.  
 
2.2.2. Al-ty and CMC-ty substrate fabrication: 
A 0.5-2% CMC-ty or 0.5-2% Al-ty solution was used to prepare either a flat or patterned 
substrate. A 0.5-1% polymer solution mixture with HRP (0.38U/ml) and 2.7mM H2O2 
solution with the volume ratio of 50:3:10 was cast directly on tissue culture dish surface. 
To pattern the gel surface, a patterned gelatin block was pressed on the gel solution 
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immediately after casting. Casted hydrogel substrate was kept for 10min at 25°C for 
complete gelation and moved to 4°C and stored overnight. To remove the gelatin block, 
the hydrogel/gelatin block was incubated with phosphate buffered saline (PBS) at 37°C, 
which dissolved the gelatin. The PBS containing the dissolved gelatin was removed and 
hydrogel was washed three times with warmed PBS to complete the gelatin removal 
process. The hydrogel substrate was kept at 37°C under PBS for 12 hours before collagen 
type-I adsorption step. To promote cell attachment, collagen type-I was adsorbed onto the 
patterned substrate surface; 3.4mg/ml collagen type-I (BD science) was diluted in ice 
cold PBS by 1:100 volume ratio, and the substrate was incubated with diluted collagen 
for 2 hours at 37°C. The substrate was vigorously washed with PBS three times at room 
temperature to remove excess collagen, and the newly collagen-coated hydrogel substrate 
was incubated at 37°C another 2 hours before seeding cells. The same procedure was also 
used to fabricate non-patterned or patterned 0.5-1% Al-ty substrates.  
To prepare stiffer film shape substrates, 1.5-2% polymer solution either CMC-ty 
or Al-ty mixed with 2-3ul of HRP (1U/ul) was cast in a gelatin mold (patterned or non-
patterned) and treated with a 2.7mM H2O2 solution for 40 min (Figure 2.2) Because Al-ty 
can be gelated by cations such as Mg2+ and Ca2+, the Al-ty film substrate was incubated 
with a 100mM MgCl2 solution mixed with HRP (1.6 units/ml) and H2O2 (2.7mM) for 10 
minutes and washed with Mg2+ and Ca2+ free PBS to achieve additional rigidity. To 
dissolve the remaining gelatin underneath the film, both film types were incubated with 
PBS at 25°C for 3 hours and moved to 37°C incubator overnight. To evaluate film 
degradability, Al-ty and CMC-ty films were incubated with the matching degrading 
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enzyme, i.e. alginate lyase and cellulase, respectively. To serve as a substrate, a CMC-ty 
or Al-ty film was glued down onto the culture dish using 1% CMC-ty or Al-ty hydrogel, 
respectively, and kept under PBS at 37°C until further processing. 
 
2.2.3. Substrate Young’s modulus/stiffness tuning to optimize the biomechanical growth 
environment of specific cell types. 
The Young’s modulus/stiffness of CMC-ty and Al-ty substrate was tuned by varying 
CMC-ty and Al-ty concentration (w/v). 1%, 2% and 4% were selected for CMC-ty, and 
1%, and 2% were selected for Al-ty. 1% CMC-ty and 1% Al-ty solution were directly 
mixed with HRP and 0.34M H2O2 to cast onto the backing film. However, due to the high 
viscosity and instant gelation, a 2% and 4% CMC-ty solution and 2% Al-ty solution 
mixed with HRP was cast in a mold covered by dialysis membrane and treated with 
2.7mM H2O2 solution for gelation. To further increase its modulus, the gelated 2% Al-ty 
was treated with 100mM MgCl2 for 10 minutes. Young’s modulus measurements were 
performed using atomic force microscopy (AFM). Five samples were prepared for each 
concentration and substrate type (CMC-ty or Al-ty), and at least three measurements 
were made for each sample. The linearized Hertzian model was used to measure Young’s 
modulus [61]. 
 
2.2.4. Growing patterned cell sheets 
Four different cell types (NIH 3T3, human mesenchymal stromal cells (hMSCs), mouse 
myoblast precursor cells (C2C12), bovine vascular smooth muscle cells (BVSMCs) were 
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used to evaluate cell attachment on patterned CMC-ty and Al-ty substrate surfaces. 
Roughly 100,000 cells/ cm2 were seeded onto a 9 cm2 substrate surface area, and kept in 
an incubator overnight to allow cell attachment. Thereafter, and media was replaced at 
regular intervals (n≥10) (Figure 2.3). 
 
2.2.5. Cell sheet transfer & stacking  
Two individually patterned cell sheets were grown to confluence, and culture media was 
replaced by culture media with collagen type-I (17ug/ml) at 37°C for 2 hours. Collagen 
type-I containing media was then completely removed from both cell sheets. One cell 
sheet, cultured on an Al-ty substrate, was lifted, flipped, and stacked on the cell sheet 
cultured on a CMC-ty substrate to make cell sheet-cell sheet contact while maintaining 
roughly 60° alignment between the two patterned cell sheets. A dialysis membrane and a 
pressure plate with multiple-pillars were placed on top of Al-ty substrate of the flipped 
cell sheet construct to enhance cell sheet-cell sheet bonding. To keep cells viable, 1 ml of 
culture media was added and incubated for 2 hours at 37°C for cell sheet-cell sheet 
bonding. Then, media was aspirated, and the pressure plate was removed. The enzyme 
specific for the top construct, alginate lyase, was mixed with pH-adjusted culture media 
(pH 6.3) added to the cell sheet stack and the dialysis membrane was lifted and removed. 
The two-sheet construct was then incubated for 1.5 hours at 37°C in the alginate lyase 
media to degrade the top Al-ty substrate. Thereafter the entire construct was washed once 
with fresh enzyme-containing media and three times with fresh media to completely 
remove the degraded Al-ty. The same procedure was repeated to stack additional cell 
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sheets.  
 
2.2.6. Cell Tracker dye staining to visualize post transfer pattern preservation  
A two or three layered patterned cell sheet stack was kept submerged in the media and 
imaged using confocal microscopy (Olympus IX81, Fluoview1000). Invitrogen™ Cell 
Tracker Green CMFDA, and Cell Tracker Red CMTPX were used to stain individual cell 
sheets, respectively according to manufacturer’s protocol. At least three samples were 
prepared to confirm the post-transfer pattern preservation. To acquire clear confocal 
images, cell sheets were transferred on fibronectin-adsorbed glass cover slips, created by 
incubating fresh cover slips with a 10ug/ml fibronectin solution at 37°C for 1 hour. 
Imaging was carried out after 24 hours of cell sheet transfer.  
 
2.2.7. Live/Dead assay for cell viability  
Cells were stained using Live/Dead® (Invitrogen) assay kit 4 and 24 hours after cell 
sheet stacking to evaluate post-stacking cell viability according to manufacturer’s 
protocol. Live/Dead staining was performed on a two-layered cell sheet stack and images 
were taken using confocal microscopy (Olympus IX81, Fluoview1000, 20X 
magnification). 
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2.3. Results and discussion 
2.3.1 Al-ty and CMC-ty substrate fabrication 
A 0.5-1% polymer pre-gel solution mixture (HRP (0.38U/ml) and 2.7mM H2O2) directly 
casted on tissue culture dish surface was gelated within 30 second for both CMC-ty and 
Al-ty. After dissolving the gelatin patterning block, a clear pattern was observed on the 
substrate surface (Figure 2.2-A). Collagen adsorption and washing did not affect the 
surface pattern. A similar protocol was used to prepare stiffer substrates. In all cases, the 
pattern was maintained after collagen type-I adsorption. To confirm substrate 
degradability, Al-ty and CMC-ty films were subjected to their matching protease, for 60 
min, at which time both CMC-ty and Al-ty substrates were found to be completely 
degraded under these conditions. The degradation rate was even faster for low 
concentration substrates (<1%).  
Because CMC and alginate are inexpensive materials and the hydrogel can be 
poured to take any shape and size, our system can be easily scale up for high throughput 
production. The sequence and timing with which the reagents are added is critical for the 
production of quality controlled modified polymers. For example, with CMC-ty synthesis 
the chemical addition sequence (NHS, HOBt, EDC) produces less unreacted chemical 
aggregates but soft hydrogels, while the sequence (NHS, EDC, HOBt) produces stiffer 
hydrogels at the same CMC-ty concentration (Table 2.1). In contrast, the timing under 
which the additions of NHS, EDC and tyramine were made was critical for the 
production of Al-ty with maximum tyramine branches on each alginate backbone unit; 
adding tyramine even one hour after NHS and EDC did not result in any tyramine 
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incorporation with alginate. In this reaction, the timing is critical because the half-life of 
activated carboxylate groups formed by NHS and EDC is short and they become 
hydrolyzed if they cannot find the amine group on target molecule, tyramine [62]. 
 
2.3.2. Various cell-types form confluent patterned cell sheets when grown on 
topographically patterned hydrogel substrates 
Using either a gelatin stamp containing 20µm ridges with 50µm grooves or patterned 
gelatin mold, we obtained clearly patterned surface (ridges (50µm) and grooves (20µm)) 
on both CMC-ty and Al-ty substrates (Figure 2.2). Type I collagen adsorption promoted 
cell attachment and proliferation. Upon cell seeding, four different cell types (bovine 
vascular smooth muscle cells, NIH 3T3 fibroblasts, human mesenchymal stromal cells 
(mMSCs), mouse myoblast precursor cells (C2C12)) formed patterned cell sheets upon 
achieving full confluence, typically occurring within 7 days of culture (Figure 2.3). For 
this type of patterned surface (3cmx3cm), 2.5x105 cells/ml was an optimal density to 
form initial cell alignment along the grooves. Although fully confluent cell sheets were 
formed within 4 days with higher seeding densities (i.e. 3.5x105 cell/ml), cell alignment 
was irregular and randomly oriented cell sheets were formed. These four cell types also 
formed confluent patterned cell sheets within 7 days of culture when fibronectin was 
added as an ECM coating instead of collagen I. Overall, these results show that both 
CMC-ty and Al-ty substrates promote the attachment of numerous cell types in a manner 
that the resulting cell sheets retain the original patterning. Therefore our hydrogel 
platform can be applied to various applications involving multiple cell types. 
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2.3.3. Stiffness-tuned substrates mimic the stiffness range in native soft tissues (<100Pa 
to 50kPa)  
To measure Young’s modulus of hydrogel substrates, both 1% CMC-ty and Al-ty 
solutions were mixed with HRP and H2O2 with an appropriate mixing ratio and casted 
between glass cover slips to fabricate flat gels for AFM measurements. The Young’s 
moduli of various hydrogel substrates produced in this manner are listed in Figure 2.4. 
While modulus of the 1% CMC-ty gel was in the 100Pa range, a 1% Al-ty gel was in the 
1900Pa range. The 2% CMC-ty gel modulus was in the 1100 Pa range, whereas the 2% 
Al-ty gel modulus was significantly higher, reaching roughly 24kPa. To achieve the 
modulus range of native muscle (about 50kPa), the 2% Al-ty gel was further crosslinked 
with Ca2+ which resulted in a two-fold increase in its Young’s modulus to roughly 48kPa. 
In a The Young’s modulus of a 4% CMC-ty gel concentration was found to be in roughly 
4kPa. The Young’s modulus range of our hydrogel substrates can thus range from 100Pa 
to 50kPa, which covers most of the native soft tissue moduli except for tendon [63]. AFM 
measurements show that the mechanical properties of the CMC-ty hydrogel substrates 
were initially limited to a lower range, but we were able to increase their stiffness more 
than 10-fold using a gelatin based dehydration method, which osmotically transferred 
water from the hydrogel substrate to liquid gelatin. 
  
2.3.4. Stacking procedure preserves cell sheet pattern and high cell viability 
Invitrogen™ Cell Tracker Green (CMFDA) and Red (CMTPX) were used to stain 
individual cell sheets grown on CMC-ty and Al-ty substrates, respectively. For a two cell 
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sheet stacks, one cell sheet grown on Al-ty substrate (red) and one cell sheet grown on 
CMC-ty substrate (green) were used. For three cell sheet stacks, one cell sheet grown on 
a CMC-ty substrate (green) was sandwiched between two cell sheets grown on Al-ty 
substrates (red) . Stacking of either two or three fully-grown cell sheets preserved the cell 
alignment pattern (Figure 2.5). A Live/Dead® assay was subsequently performed on two 
cell sheet stacks 4 and 24 hours (n = 3) after stacking the procedure; in both cases the 
results showed more than 99% of post stacking viability. This result suggests that our 
system provides a cell friendly environment during both the cell sheet culture and 
stacking processes (Figure 2.6).  
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2.4. Figures and Tables 
 
Figure 2.1 Modification of natural polymer, carboxymethyl cellulose (CMC) and alginate 
(Al); A, B. Adding a tyramine branch to carboxy group of CMC and Al by forming an 
amide bond (CMC-ty & Al-ty) C. gelation of CMC-ty or Al-ty by horseradish peroxidase 
(HRP) via a random crosslinking reaction [64] 
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Table 2.1. Weight (g) of chemical ingredients used to synthesize tyramine conjugated 
carboxymethyl cellulose (CMC-ty) (A) and alginate (Al-ty) (B) 
 
 
 
 
 
 
 
Figure 2.2 Fabrication of patterned hydrogel substrates (CMC-ty or Al-ty) In a patterned 
gelatin mold, pre-gel solution (CMC-ty or Al-ty) is poured and covered with a dialysis 
membrane to immobilize the pre-gel solution. A mesh is placed on top of the membrane 
and 0.5% (V/V) H2O2 in PBS is added to initiate the gelation process. A glass weight is 
placed on top of the mesh to make surface flat. The gelation process is carried out at 4⁰C 
for 40 minutes. A-B. Patterned substrate surfaces. Each scale bar is 100µm   
(A) CMC NHS EDC HOBt Tyramine 
Grams added to 60ml 0.05M 
MES buffer, pH 6.0 
0.6 0.024 0.150 0.120 0.477 
(B) Alginate NHS EDC Tyramine 
Grams added to 60ml 0.1M 
MES buffer, pH 6.0 
0.3 0.435 1.449 2.7 
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Figure 2.3 Confluent and patterned cell sheet formed with various cell types on patterned 
hydrogel substrates. Bovine vascular smooth muscle cells (BVSMCs), human 
mesenchymal stem cells (hMSCs), mouse fibroblast (NIH-3T3), and mouse myoblast 
precursor cells (C2C12s) were seeded and formed confluent cell sheets within 7 days. A. 
BVSMCs sheet B. hMSCs sheet C. NIH-3T3 sheet, D-E. C2C12 sheet; E.20x 
magnification image, F. 20x magnification immunofluorescent image showing nuclear 
(DAPI) and Actin Filaments staining. Scale bar is 100µm. 
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Figure 2.4 AFM measurements on concentration adjusted CMC-ty and Al-ty hydrogel 
substrates  
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Figure 2.5 Cell sheet stacking method and post stacking pattern preservation analysis. 
One patterned cell sheet grown on a CMC-ty hydrogel and a second patterned cell sheet 
grown on an Al-ty hydrogel were stacked together. The entire cell sheet-Al-ty hydrogel 
construct was flipped over and placed on the cell sheet resting on the CMC-ty hydrogel, 
and the two were bonded by exerting light pressure, while the stacked sheets were then 
incubated in media containing alginate lyase to specifically degrade the top Al-ty film. A-
B. CMC-ty and Al-ty construct C. Stacked two cell sheet constructs; top (orange color) is 
Al-ty construct and bottom (blue color) is CMC-ty construct D. Two cell sheet stack 
ready for another stacking or immediate implantation. E. Pattern preservation after 
stacking (two cell sheet stack; pattern was visualized with cell tracker Green and Red 
respectively).  
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Figure 2.6 Live/Dead assay 24 hours after stacking; A. non-patterned 2 cell sheet stack B. 
patterned 2 cell sheet stack 
 
 
2.5. Summary  
This technology represents a new innovation and key step in the development of 
engineered tissue. Cell sheet technology was originally developed in the mid-1980’s as a 
scaffold-free approach for tissue engineering. However, the primary disadvantage of this 
system resides in the fact that cell sheet generation has been limited to thermo-responsive 
poly(N-isopropylacrylamide) (PIPAAm) coatings on rigid surfaces that fail to accurately 
mimic the native biomechanical growth environment (i.e. substrate stiffness) of the target 
tissues. In contrast, we have developed a novel cell sheet culture and transfer system 
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based upon an enzymatically degradable versatile hydrogel platform that does not 
compromise mammalian cell and ECM structure or function during the degradation 
process. This state-of-the-art system has the capability to tune hydrogel substrate stiffness 
to match the stiffness of the native target tissue, which will presumably allow it to be 
applicable the development of any engineered tissue. Our cell sheet technology offers 
several advantages such as stiffness control, scalability for automated mass production, 
and a cell friendly environment (37°C under media) for the entire cell sheet culture and 
transfer procedure that maintains and ensures high cell viability (>99%). This system 
equips us with the potential to develop autologous living engineered tissue replacements 
that recapitulate native tissue properties to a high degree at low cost. 
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Chapter 3: Aim 2 
3.1. Motivation  
Cells respond to their growth environment, especially substrate modulus [44]. After 
developing fully functional system for producing hydrogels over a wide range of stiffness, 
we next used them to examine the effect of hydrogel stiffness on cell sheet formation. In 
these studies, we specifically examined the effect of substrate stiffness on the 
composition of secreted ECM, especially collagen type I since collagen is the strongest 
and the last ECM structural component recruited when tissue are under mechanical stress 
[65]. Therefore, we hypothesized that substrate stiffness could alter cell sheet 
mechanical properties, especially failure stress by inducing collagen type I content 
change. At the same time, we also examined the effect of substrate stiffness on myogenic 
differentiation. We hypothesized that myogenic differentiation also will be strongly 
influenced by the stiffness of the surface they are grown on. We used a collagen type-I 
ELISA assay to investigate the effect of stiffness on ECM secretion, reasoning that 
collagen is a major ECM component substantially contributing to structural rigidity 
especially upon tissue rupture [65][66] (Figure 3.1-A). Then, we used a uniaxial cell 
sheet stretcher and force sensor [52] to measure cell sheet maximum stress at ~250% 
strain before and after treatment of collagenase type I. This was done to verify that 
collagen type I is in fact a major structural component that affects cell sheet mechanical 
strength. Next, we measured maximum failure stress of cell sheets in order to assess cell 
sheet mechanical strength according to collagen type I content change.  
To investigate the effect of hydrogel stiffness on myogenic differentiation, we 
used two well-known differentiation markers, namely myogenin, a marker indicating 
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early stage of differentiation and myosin heavy chain (MYHC)(MF20) as an indicator of 
matured myotube formation to examine myotube development on very soft (<250Pa) 
substrates, native muscle stiffness matched (11-13kPa) substrates, and tissue culture 
plastic (~3GPa). In these studies, we used q-PCR and immunofluorescent staining to 
detect MYHC (MF20) and myogenin mRNA and protein expression, respectively. 
 
3.2. Methods 
 
3.2.1. Effect of Hydrogel Stiffness on ECM composition as assessed from collagen type I 
content (ELISA) 
We investigated how collagen type-I secretion changes with substrate stiffness. We chose 
to measure collagen type-I secretion because it is the major component of ECM that 
strongly relates cell sheet mechanical strength [66]. Soft (<250Pa) and native muscle 
stiffness (10-13kPa) matching substrates for both CMC-ty and Al-ty were prepared. 
Mouse myoblast precursor cells (C2C12) were seeded (1.0x104 cells/cm2) and cultured 
until cells form confluent cell sheet. Cells were fixed with 4% paraformaldehyde (20 min 
at room temperature) and washed three times with PBS. Nonspecific antibody binding 
was blocked by adding 3% bovine serum albumin (BSA) in TBS (Tris-buffered saline) 
and incubating overnight on a rocker platform at 4°C. Then, samples were washed four 
times with TBS. Samples were then incubated with collagen type-I primary antibody 
(rabbit, Rockland Immunochemicals, Cat 600-401-103) (2ug/ml) in 3% BSA-TBS for 
1.5hr at room temperature on a rocker platform. After a 1.5hr incubation, cell sheets were 
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washed five times with TBS and then incubated at room temperature for 30 min with 
secondary antibody (goat anti-rabbit HRP-linked IgG, Jackson Immunochemicals, Cat 
111-035-003) at 0.5µg/ml for 30 min. The cell sheets were washed three times with TBS 
with 0.1% Tween 20 and 5 times with 200ul TBS. Before the last wash, developing 
solution (TMB Microwell Peroxidase Substrate System, KPL) was prepared in a foil-
wrapped tube. Cell sheet samples were incubated with TMB developing solution until 
blue color development after approximately for 1 minute, and the reaction was stopped 
by adding 1N sulfuric acid (100µl per 1ml of developing solution). An aliquot was taken 
from each sample and transferred into a 96 well plate. Absorbance was read in triplicate 
at 570 nm (nonspecific background) and 450 nm (specific signal) within 30 minutes of 
stopping the reactions. The absorbance values were averaged and the background was 
subtracted from the specific 450 nm signal to obtain the relative collagen I absorbance. 
These values were normalized to the cell sheet dry weight (N= 10 for each substrate and 
modulus type) and quantitated against a collagen type-I standard curve. A one-way 
ANOVA test was performed to determine statistical significance on all measurements 
and significant difference was accepted with p-value (0.01).  
 
3.2.3. Effect of substrate stiffness on cell sheet mechanical strength 
We hypothesized that cell sheet collagen type I content change due to substrate stiffness 
modulation would also change cell sheet mechanical property as well. Although we 
verified that collagen type I is a major ECM component and the strongest and last 
component recruited during tissue mechanical loading [65][66], we wanted to confirm 
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that the same principle applies to our cell sheets. Thus, we performed a collagenase 
treatment test. Muscle stiffness (10-13kPa) substrate grown cell sheet was subjected 
uniaxial stretch before and after treatment with degrading enzyme, collagenase type I 
(100U/ml) for 30 min. To make sure that second time stretching does not alter total cell 
sheet viscoelastic properties, the same muscle stiffness substrate grown cell sheet were 
stretched again with 200~250% strain without collagenase treatment to serve as a control. 
Then, we compared cell sheet failure stress change between soft (<250Pa) and muscle 
stiffness (10-13kPa) substrate grown cell sheets for each substrate type to investigate the 
effect of substrate stiffness on cell sheet mechanical properties. Individual cell sheets 
were stretched until rupture to measure maximum failure strength. One way ANOVA test 
was performed to determine statistical significance on all measurements and significant 
difference was accepted with p-value (0.01). 
 
3.2.3. Gene expression analysis 
To understand the effect of substrate modulus on skeletal muscle cell sheet development, 
we examined how gene expression profiles change with substrate stiffness. We focused 
on two differentiation and proliferation related genes, Myosin Heavy Chain (MYHC) and 
Myogenin (MYOG). C2C12 cells were grown on either CMC-ty or Al-ty substrates, each 
at two different Young’s moduli (<250Pa or 10-13kPa). For the first three days, cells 
were grown using a “high glucose” medium composed of 4.5g/L D-Glucose Dulbecco's 
Modified Eagle Medium (DMEM) (Life Technologies, 11995081) supplemented with 10% 
Fetal Bovine Serum (FBS) (Hyclone, SH30910.03) and 1% Antibiotic-Antimycotic 
  
38 
(ABAM) (Life Technologies, 15240-112). Thereafter they were differentiated in a “low 
glucose” differentiation medium (Life technologies, 11885092) supplemented with 2% 
horse serum (HS) (Hyclone, 26050088) and 1% ABAM for another 4 or 10 days. The 
resulting cell sheets were harvested from their substrates using the appropriate protease 
(cellulase for CMC-ty and alginate lyase for Al-ty) and washed twice with ice cold PBS. 
RNA was extracted with TRIzol reagent (Invitrogen, Carlsbad, CA) according to the 
manufacturer’s instructions. 1µg RNA was reverse-transcribed with the High Capacity 
cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA, USA). Analysis 
of gene expression was performed by TaqMan assays (Applied Biosystems, Foster City, 
CA, USA) on an ABI 7300 Real Time PCR system. 18s ribosomal subunit RNA served 
as endogenous control, and gene expression was calculated by using the ΔΔCt method. A 
one-way ANOVA test was performed to determine statistical significance on all 
measurements and significant difference was accepted with p-value (0.01).  
 
3.2.4. Immunohistochemical analysis 
We performed immunohistochemical analysis to conform the result obtained from PCR 
analysis. C2C12 cells were grown on either CMC-ty or Al-ty substrates, each at two 
different Young’s moduli (<250Pa or 10-13kPa). For the first three days they were grown 
using a “high glucose” medium composed of 4.5g/L D-Glucose Dulbecco's Modified 
Eagle Medium (DMEM) (Life Technologies, 11995081) supplemented with 10% Fetal 
Bovine Serum (FBS) (Hyclone, SH30910.03) and 1% Antibiotic-Antimycotic (ABAM) 
(Life Technologies, 15240-112). Thereafter they were grown in a “low glucose” 
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differentiation medium (Life technologies, 11885092) supplemented with 2% horse 
serum (HS) (Hyclone, 26050088) and 1% ABAM for another 4 or 10 days. Myotube 
formation was confirmed under phase contrast microscopy (Nikon™) before further 
processing. Cells were fixed with 4% paraformaldehyde for 10 minutes and washed three 
times with cold PBS. Cells were blocked for 60 minutes with 2% BSA, 2% goat serum, 
and 0.1% Triton X-100 in 1 x PBS containing mouse on mouse blocking solution (Vector 
laboratory), and sections were incubated with primary antibody against either Myosin 
heavy chain (Clone MF 20) or Myogenin (eBioscience San Diego, CA; Cat # 14-6503 
and 14-5643 respectively) at a 1:50 dilution for 2 hours at room temperature. Cells were 
subsequently washed 5 times, 3 minutes each with the wash buffer (1x PBS containing 
0.05% Tween 20), and then incubated in goat-anti mouse Alexa Fluor 488 antibody in the 
dark for an hour. Nuclei were stained with 0.1g/mL DAPI for 5 minutes followed by 
washing as described above. Cells were mounted with Vectashield (Vector Laboratories), 
and a Nikon DSFi1 camera head attached to a Nikon ECLIPSE 50i light microscope 
system was used to capture images of stained sections. Morphometric analyses were 
performed using NIS-Elements Basic Research 3.0 software. Differentiation markers and 
fusion index (number of nuclei per myotube) were evaluated, and quantitative Myosin 
heavy chain (MYHC) (MF20) and Myogenin expression were assessed. A one-way 
ANOVA test was performed to determine statistical significance on all measurements 
and significant difference was accepted with p-value (0.01).  
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3.3. Results and discussion 
3.3.1 Collagen type I content increases in proportion to substrate stiffness  
Collagen type I is the major ECM component, comprising up to 60% of total ECM in 
muscles and tendons, and is also the primary determinant of structural rigidity [66]. 
Although many proteins such as laminin and fibronectin also respond to mechanical 
loading (i.e. stretching), the preponderance of collagen type I means that it is the main 
determinant of the force required to achieve tissue sheet failure. Using a Collagen type I 
ELISA assay, we thus investigated the effect of substrate stiffness on collagen type I 
secretion. When substrate stiffness was increased from the 100Pa range to the 10kPa 
range, collagen type I secretion was increased more than 3 fold (Figure 3.1-B). This 
result matches well with those reported previously [67]. While the most straightforward 
explanation for this finding would be alterations in Collagen type I mRNA expression, it 
is also possible that it is due to be the higher secretion of collagen-degrading matrix 
metalloproteinases (MMPs) that has been reported with softer substrates [61].  
  
3.3.2. Cell sheet failure stress increases in proportion to substrate stiffness 
Because collagen type I is the most abundant and toughest ECM component, it is a 
reasonable hypothesis that collagen type I determines cell sheet failure strength. To 
confirm this hypothesis, cell sheets were subjected to stretching before and after 
collagenase type I treatment. After collagenase type I treatment, maximum stress was 
significantly lowered by more than 5 fold (Figure 3.2-C). This result supports our 
hypothesis that collagen type I is indeed a major ECM component responsible for 
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structural strength in our cell sheets. We next compared the failure stress of cell sheets 
grown on soft substrates (200Pa range) with those grown on stiff substrates (10kPa 
range). As expected from their relative collagen contents, the failure stress for cell sheets 
grown on stiff substrates was significantly higher (Figure 3.3).  
 
3.3.3. Immunofluorescent and q-PCR analysis; substrate stiffness regulates 
differentiation efficiency/maturation  
The biomechanical environmental is well known to impact cell differentiation [57], and 
hence is likely to be a critical factor in any protocol designed to recapitulate the 
properties of native cell sheets. A major advantage of our cell sheet culture and transfer 
system is that it gives us the capability to tune hydrogel substrate stiffness to match those 
of native target tissues. To demonstrate this advantage, we assessed the differentiation of 
C2C12 myoblast grown on soft (<250Pa), muscle stiffness (10-13kPa) hydrogels, and 
tissue culture plastic (~3GPa). In this study, the 10-13 kPa stiffness mimics the native 
stiffness of skeletal muscle. We cultured and differentiated C2C12 cells for 4 or 10 days, 
and differentiation was assessed by quantifying myogenin, an early differentiation marker, 
and MYHC, a late differentiation marker. Immunofluorescent (IF) technique was used to 
determine protein levels and q-PCR analysis was used to quantify mRNA levels. 
Myogenesis is a highly coordinated process driven by spatial and temporal 
expression of myogenic regulatory factors (MRFs) - MyoD, Myf5, myogenin and Mrf4 
(or Myf6), and myocyte enhancer factor-2 (MEF2) family [68]. Myogenin drives early 
stage of myogenesis, inducing myoblasts fusion into multinucleated myofibers and it has 
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been reported that highly increased myogenin expression level was kept at least for 96 
hours after initiation of myogenesis (Figure 3.4-A). Myosin heavy chain (MYHC) 
appears as a late differentiation marker [68]. Kontaridis et al. (2001) reported that 
myogenin starts expressing 12h after the initiation of differentiation and MYHC show up 
48h after the initiation of differentiation (Figure 3.4-B). Cabane et al. (2003) also showed 
that myogenin is absolutely required for MYHC expression (Figure 3.4-C). We 
hypothesized that we could induce optimal differentiation on native muscle like stiffness 
(10-13kPa) tuned hydrogel substrate. We investigated the efficiency of differentiation 
using six indices (Table 3.1). 
 
Fusion index, efficiency of differentiation, was higher in soft substrate and TC plastic 
grown cells at differentiation Day 4 but became opposite at Day 10; index 1 
Fusion index is used to evaluate the efficiency of myogenic differentiation. Addition to 
fusion index, qualitative morphological evaluation such as length, thickness, number of 
nucleus per myotube could also show the efficiency of myogenic differentiation. Fusion 
index was higher for both soft substrate and TC plastic grown cells (Figure 3.5-A) on 
Day 4. This result was opposite from what we expected and also contradictory to 
previously reported findings. We compared this result with myogenin and MYHC gene 
activity on Day 4. Interestingly, q-PCR result showed that myogenin and MYHC were 
more than 2 fold upregulated for the cells grown both Al-ty and CMC-ty muscle stiffness 
(10-13kPa) substrates at 96 hours of differentiation (Figure 3.7). This contradictory IF 
and q-PCR results led us to hypothesize that the differentiation time scale might be 
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slower on muscle stiffness (10-13kPa) substrate than soft or TC plastic substrate. In order 
to test this hypothesis, we investigated the degree of differentiation at Day 10. Because 
we observed that cellular response and behavior were not affected by polymer type 
(CMC-ty or Al-ty) but by stiffness, we investigated the degree of differentiation at early 
(Day4) and later stage (Day 10) in three categories; soft (<250Pa), muscle stiffness (10-
13kPa) and TC plastic (~3GPa) serving as a control. Fusion index at day 10 of 
differentiation was exactly opposite to the fusion index at day 4 of differentiation; cells 
grown on muscle stiffness (10-13kPa) substrate showed highest fusion index whereas, 
fusion index of soft (<250Pa) and TC plastic (3GPa) did not significantly change (Figure 
3.5-A). Qualitative morphological evaluation also showed that on muscle stiffness 
matched substrate grown and differentiated cells formed thickest and longest individual 
myotubes (Figure 3.8-B,D,F) although the number of myotubes and fusion index were 
lowest in muscle stiff substrate grown cells at Day 4. In this experiment, we thus, 
reproduced previously reported biomechanical findings; the best myogenic differentiation 
condition is when substrate stiffness was matched native muscle stiffness (10-13kPa) [57]. 
However, from fusion index alone, we could not explain the gradual differentiation 
efficiency change over a time course of 10 days. Because myogenin not only has an 
expression time profile and but also is absolutely required in order for MYHC to be 
expressed, we hypothesized that early stage myogenin activity could closely relate to 
myotube development. To address this question, we searched a potential mechanism that 
links myogenin activity and substrate stiffness, and we quantitatively analyzed IF results 
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of differentiation day 4 and day 10 to understand the role of myogenin using 5 
measurement indices (Table 3.1). 
 
Only significant change in overall myogenin expression was observed in stiff substrate 
grown cells between day 4 and day 10 
Whereas no significant change in overall myogenin expression was observed in both soft 
substrate and TC plastic grown cells between day 4 and day 10, more than 5 folds 
reduction was observed only in muscle stiffness matched substrate grown cells (Figure 
3.5-B) (Table 3.1. index 2). These results may suggest that substrate stiffness could 
control myogenic differentiation by focal adhesion kinase (FAK) mediated myogenin 
expression. This hypothesis could be further supported from the measurement of the 
number of myogenin+/MYHC- (Table 3.1. index 3) and myogenin+/MYHC+ single cells 
(index 4) showing potential for additional myotube formation.  
 
More myogenin+/MYHC- and myogenin+/MYHC+ single cells were found in both 
muscle stiffness substrate and TC plastic grown cells on day 4, but significant reduction 
of both cell type was shown only in muscle stiffness substrate grown cells at day 10 
To identify potential cell populations contributing to additional myotube formation, we 
measured the percent of myogenin+/NYHC- single cells (out of total number of nuclei in 
the field of view, Table 3.1. index 3) and myogenin+/MYHC+ single cell ratio from total 
number of nuclei in MYHC+ single cells and myotubes (Table 3.1. index 4). Because 
myogenin is absolutely required in order for MYHC to express, myogenin+/MYHC- cells 
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are at earlier stage of differentiation than myogenin+/MYHC+ cells. However, both type 
single cells will eventually fuse to form myotubes. Similar to total myogenin expression 
change (Figure 3.5-B), percent of myogenin+/MYHC- single cells was reduced more 
than 3 folds at differentiation day 10 (Figure 3.5-C). Furthermore, the measurement of 
myogenin+/MYHC+ single cell ratio from total number of nuclei in MYHC+ single cells 
and myotubes showed more than 10 folds reduction at day 10 (Figure 3.5-D). These 
results could suggest that within 10 days of differentiation, most cells expressing 
myogenin fused to form myotubes and were ready to proceed the next stage of 
differentiation when grown on muscle stiffness substrate (10-13kPa). On the other hand, 
it seems like differentiation time scale is disturbed when cells are grown on either too soft 
(<250Pa) or too stiff (~3GPa) substrate.  
 
Further supporting evidence of myotube maturation within 10 days on muscle stiffness 
substrate are from the measurement of the ratio of myogenin+ nuclei in myotubes and 
overall MYHC expression 
Maturation of myotubes within 10 days on muscle stiffness substrate could be further 
supported by significant reduction in the ratio of myogenin+ nucleus in myotubes (Table 
3.1. index 5) only in muscle stiffness substrate grown cells whereas soft substrate and TC 
plastic grown cells showed slightly elevated or similar level of myogenin+ nucleus ratio 
in myotubes between day 4 and day 10 (Figure 3.5-E). Furthermore, overall 
differentiation capacity assessment by measuring the percent of nucleus in MYHC+ 
single cells and myotubes out of total number of nucleus in the field of view (Table 3.1. 
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index 6) also showed that cells grown on muscle stiffness substrate had the highest 
differentiation capacity (Figure 3.5-F).  
 
Rationales to explain disturbed differentiation on too soft (<250Pa) and too stiff (3GPa) 
TC plastic substrate 
S.-W. et al. reported that substrate stiffness regulates myogenin expression via focal 
adhesion kinase (FAK or PTK2) interaction with heterochromatin (Figure 3.6) [69]. FAK, 
a major cell adhesion-activated tyrosine kinase, has an important function in cell 
adhesion and migration. FAK interacts with MBD2 (methyl CpG-binding protein 2) [69]. 
Inside nucleus, FAK–MBD2 complexes causes heterochromatin reorganization and 
decrease MBD2 association with HDAC1 (histone deacetylase complex 1) and methyl 
CpG in the myogenin promoter, so, inducing myogenin expression [69]. Also, Engler et 
al. and Quach et al. showed FAK/PK2 expression increased as substrate stiffness 
increased [57][70]. So if FAK signaling is one of the strong driving forces to regulate 
myogenin, myogenin expression could be regulated by substrate stiffness. Based on this 
hypothesis, we analyzed myogenin activity affecting myogenic differentiation. 
Mastroyiannopoulos et al. reported that continuous down regulation of myogenin 
reverses terminal muscle differentiation by inducing myotubes to re-enter the cell cycle 
[71]. Janot, M. et al. (2009) also showed that maintaining myogenin activity is critical for 
cells to enter and remain in the differentiation cycle [72]. However, Weise et al. (2006) 
suggested continuously expressed myogenin could interrupt myotube formation and 
maturation [73]. We already suggested FAK mediated myogenin regulation. Therefore, 
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combining these two rationales, we suggest the following mechanism that substrate 
stiffness changes cellular response especially in myogenic differentiation; in soft (<250 
Pa) substrate, low FAK expression drives early down-regulated myogenin pushes back 
cells out of differentiation cycle to re-enter into proliferation cycle. However, the low 
serum condition continuously forces cells toward the differentiation pathway. Therefore, 
cells grown on too soft substrate may not be able to maintain either proliferation or 
differentiation and eventually will die.  
In contrast, in too stiff TC plastic (~3GPa) grown cells, FAK mediated myogenin 
upregulation, which keeps myogenin expression continuously high. However, myogenin 
is gradually down regulated in normal myogenin temporal profile during late stage of 
differentiation to proceed to next stage of differentiation to form a myofiber (Figure 3.4-
A). However, continuously upregulated myogenin expression due to high FAK 
expression might keep myotubes from proceeding further to form myofibers so fusion 
index at early stage of differentiation (Day 4) was maintained until late stage of 
differentiation (Day 10). 
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3.4. Figures and Tables  
 
 
Table 3.1 Myogenic differentiation efficiency measurement indices 
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Figure 3.1 Substrate stiffness has direct effect on collagen type I secretion; A. indication 
of collagen as the strongest and last component recruited during tissue mechanical 
loading [74] B. Collagen type I content change due to substrate stiffness change 
regardless of substrate type. * indicates p<.05 vs. <250Pa CMC-ty and <250Pa Al-ty. 
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Figure 3.2 Cell sheet mechanical strength change after the collagenase type I treatment; A. 
repeated stretch without collagenase type I treatment (control) B-D. Stretch before and 
after collagenase type I treatment (100U/ml, 30min) * indicates p<.05 vs. collagenase 
type I treated cell sheet. 
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Figure 3.3 Substrate stiffness effect on cell sheet failure stress; regardless of substrate 
type, cell sheets stretched showed significant difference in maximum failure stress. A. 
Stretch curve of cell sheet grown muscle stiffness substrate (10-13kPa) and soft (<250Pa) 
substrate respectively B. Maximum failure stress change between muscle stiffness 
substrate (10-13kPa) grown cell sheet and soft (<250Pa) substrate grown cell sheet. 
*indicates p<.05 vs. soft (<250Pa) CMC-ty and soft (<250Pa) Al-ty. 
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Figure 3.4 Associated gene profile and expression order during C2C12 differentiation; 
A. myogenin activity over the time course of 11 days [72] B. expression start time for 
myogenin and myosin heavy chain (MYHC) [75] C. requirement of myogenin for 
MYHC expression (DM:differentiation media, SB: p38 inhibitor) [76] D. illustration of 
time profile of myogenin, MYHC and myotube formation 
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Figure 3.5 Effect of substrate stiffness on various indices of C2C12 cell differentiation at 
Day 4 and Day 10.; A. Fusion index (percentage of nuclei in myotubes) B. percent of 
myogenin in total nuclei in the field of view C. percentage of myogenin+/MYHC- single 
cells D. percentage of myogenin+/MYHC+ single cells E. fraction of myogenin+ nuclei 
in myotubes F. percentage of nuclei in MYHC+ cells and myotubes 
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Figure 3.6 Focal adhesion kinase (FAK) regulates myogenin expression [69]; A. 
myogenin down-regulation due to FAK suppression B. down regulated myogenin over 
48h time period due to FAK suppression C. FAK suppression effect on genes critical for 
myogenic differentiation including myogenin D. illustration of FAK mediated myogenin 
regulation 
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Figure 3.7 Gene expression change due to substrate stiffness (q-PCR) at differentiation 
day 4 (96hours); A-B. myogenin and eMYHC expression change respectively for cells 
grown on Al-ty substrate C-D. myogenin and eMYHC expression change respectively for 
cells grown on CMC-ty substrate  
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Figure 3.8 Time point comparison; comparison of degree of differentiation (MYHC 
merged with Myogenin) at day 4 and day 10. A-B. Soft substrate (<250 Pa) C-D. Stiff 
substrate (10-13kPa) E-F. Tissue culture plastic (~10MPa). Scale bar is 100µm. 
  
59 
3.5. Summary  
We developed a versatile cell sheet culture and transfer system based on enzyme-
degradable hydrogel substrates in which stiffness can be tuned within the range found in 
most soft tissues. We used collagen ELISA to confirm that ECM composition can be 
modulated by substrate stiffness; collagen type I content of the deposited ECM was 
significantly higher at native tissue stiffness (10-13kPa) than at soft (<250 Pa) substrate. 
Throughout collagenase type I treatment and mechanical stretching, we also 
demonstrated cell sheet mechanical property could be optimized by matching substrate 
stiffness to target cell type native stiffness; skeletal muscle cell sheet grown on native 
muscle stiffness substrate exhibited stronger failure stress than soft substrate grown cell 
sheet. q-PCR and immunofluorescence analysis also showed that we could induce or 
keep cell native phenotypic characteristic by modulating substrate stiffness; the myogenic 
differentiation efficiency was highest on native muscle stiffness matched substrates, but 
not on softer substrates or (significantly harder) tissue culture plastic. Therefore, based on 
these results, we conclude that our system successfully incorporated substrate 
biomechanics in order to create optimal biomechanical growth environment to elicit 
proper cellular response that is critical to build a functional engineered tissue. 
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Chapter 4: Aim 3 
4.1 Motivation  
Lastly, we hypothesize native muscle stiffness (10-13kPa) matched substrate grown 
C2C12 cell sheets closely resemble native muscle cell characteristics and therefore a 
three C2C12 cell sheet stack as a 3D tissue model could survive and proliferate when 
implanted. To test this hypothesis, we will implant a 3-sheet stack of differentiated 
C2C12 cells into 8 week- old female nude mice and assess their viability 25-30 days after 
implantation. At least 2 endothelial cell/blood vessel markers will be used to determine 
whether there is angiogenic vascularization, and cell proliferation also will be 
investigated. Over all, this study should be a further step towards establishing the 
feasibility of using our enzyme degradable hydrogel platform system in the construction 
of implantable 3D engineered tissues. 
 
4.2. Methods 
Nine Nu/Nu Balb C 8-week old female mice were purchased from Charles River. After 
allowing the mice to acclimatize for 72 hours, 3 sheet stacks of C2C12 cells were 
implanted subcutaneously according to the IACUC protocol 13-028. For each mouse, an 
area of up to 3 cm x 3 cm on either dorsal flank of the mouse was prepared, and a scalpel 
or sharp tissue scissors were used to create a 2 cm x 2 cm “L” shaped incision in the 
subcutaneous space, creating a triangular skin flap and wound bed. We then used blunt 
dissection to mobilize the newly created skin flap, which created additional space for 
construct implantation (Figure 4.1-B). The cell sheet construct was then placed directly 
onto the wound bed. Finally, the incision was closed, initially with skin glue and later 
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through suturing in a manner such that the four corners of cell sheet stack were sutured 
between the skin and muscle. This procedure insured that the cell sheet was immobilized. 
All surgical procedure followed approved IACUC protocol 13-028. 
 After 25-30 days, the implants were retrieved, and similarly-sized normal tissue 
samples were also harvested from the contralateral dorsal flank to serve as a negative 
control. All collected tissues were fixed with 4% paraformaldehyde for 24 hours and 
transferred to 70% ethanol for an additional 24 hours, after which they were dehydrated. 
In the dehydration process, tissue samples were immersed in 70% ethanol for 1 hour, 
transferred to 95% Ethanol for 1 hour, and then immersed 3 times (1 hour each) in fresh 
100% Ethanol. Then, tissue samples were treated twice with fresh Thermo Shandon 
Xylene substitute for 1 hour each. Lastly, tissue samples were submerged in paraffin for 2 
hours. Paraffin was replaced after 1 hour. Tissue samples then were embedded in paraffin 
blocks and stored at 4°C until microtome sectioning. Paraffin block-embedded tissue was 
cut into 7µm slices, which were subsequently mounted on positively charged glass slides 
and then moved to slide warmer prior to the deparaffinizing process. Paraffin was 
removed by warming the slides at 60°C for 15 min and then treating them twice with 
Xylene Sub (10 min each time). Slides were treated with Xylene : Ethanol (1:1) for 5 min, 
100% ethanol for 5 min, 95% ethanol for 5 min, 70% ethanol for 5 min, and washed with 
DI water for 5 min respectively. The antigen retrieval step involved placing the slides in a 
Decolaker pressurized chamber at 90°C for 35 min, followed by an addition 10 min at 
85°C. 
For tissue staining, slides were treated with peroxidase 1 for 10 min and washed 
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with Tris-Buffered Saline and Tween 20 (TBST), and blocked with Rodent Block M 
(blocks Mouse IgG) for 30 min followed by TBST. Primary antibody was applied for 2 
hours at room temperature and secondary antibody was applied minimum 30 min at room 
temperature. Secondary antibody incubation varied due to manufacturer’s instructions. 
Slides were washed with TBST and treated with chromagen dab (3,3’-diaminobenzidine 
tetrahydrochloride) for 5 min. Slides were washed twice with deionized water and treated 
with hematoxylin for 3 min and washed with TBST. Before applying DAPI containing 
mounting media, slides were treated with 70% ethanol for 5min, 95% ethanol for 5 min, 
100% ethanol for 5 min, Xylene Sub (10 min) x 2. Slides were air dried and mounted for 
imaging. 
 
4.3. Results and discussion 
Five days after implantation, cell sheet insertion site started to bulge, and by day 25, the 
insertion site was noticeably swollen. The insertion site continued to swell up until the 
end of the experiment on day 30, when the implants were retrieved for analysis. 9 
implants and 3 controls were fixed and further processed to make paraffin embedded 
sections. All paraffin embedded tissue was cut into 7µm thick sections using microtome 
and subjected to immunofluorescent analysis. Two antibodies (CD31/PECAM-1 and 
isolectin) were used to identify blood vessels entering the implants via angiogenesis. Also 
TER-119, marker for erythrocytes (red blood cells) was co-stained with isolectin to 
confirm the presence of blood. Ki-67 antibody was used to detect proliferating cells in 
implant. However, because these proliferating cells could come from the host and C2C12 
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cells were not labeled at the time of implantation, H-2Kk was used as a marker to 
differentiate C2C12 cell sheet implant from the host tissue. H-2Kk is one of 11 genes 
encoding heavy chain as one of trimers consisting of MHC class I molecules (MHC-I). 
MHC-1 molecules are recognized by immune cells such as CD8+ T lymphocytes and play 
an important role during the cellular immune response [77]. Because Nu/Nu Balb C lines 
do not express H-2Kk but C2C12 cells do, this protein can serve a marker to establish the 
source of proliferating cells in implants. 
 As a platelet/endothelial adhesion molecule CD31/PECAM-1 staining showed 
the trace of platelets/endothelial cells near vessel lumen (Figure 4.2). Because the 3-cell 
sheet stack consisted of only C2C12 cells at the time of implantation, the presence of 
CD31/PECAM-1 positive cells suggests that endothelial cells penetrated into cell sheets. 
This result encouraged us to further investigate the presence of blood vessels and blood. 
Next, we targeted Isolectin-IB4, a protein (~114 kDa) known to bind to microglia, group 
B erythrocytes, perivascular cells, and endothelial cells [78]. We used FITC conjugated 
Isolectin-IB4 and TER-119 to stain vessel lumens and red blood cells respectively. Slides 
from normal tissue (positive control) definitively show vessel cross-sections in which 
Isolectin-IB4 stains the endothelium surrounding the lumens and TER-119 stains red 
blood cells within them (Figure 4.3-A,B,C,D). These results confirm that our implanted 
cell sheet construct recruited new blood vessels as it expanded.  
 The observation that the area over the implant continued to swell throughout the 
30-day time course of the experiment also suggested that the cells within the implant 
could be proliferating. To address this question, we stained our sections for Ki-67 protein, 
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which is strictly associated with cell proliferation. During interphase, Ki-67 can be only 
detected within the nucleus, and most of the protein is relocated to the surface of the 
chromosomes during mitosis. Because the Ki-67 protein is present during all active 
phases of the cell cycle (G1, S, G2, and mitosis), but not in resting cells (G0), Ki-67 is an 
ideal marker to determine a fraction of growing cells from a given cell population [79]. In 
Figure 4.4, it can be seen that Ki-67 positive cells were detected throughout the entire 
cross section. Taken together these results indicate cells in the cell sheet implant 
integrated to host tissue sufficiently to recruit blood vessels for the nutrition and gas 
exchange, and this active remodeling allowed cells within the implant to proliferate. 
However, these results still leave open the question of whether the proliferating cells 
were C2C12 cells or invading host cells. To address this question, we conducted staining 
for H-2Kk, a histocompatibility antigen that is present in C2C12 cells but not nude mice. 
In Figure 4.5 it can be seen that H-2Kk was detected in numerous cell bodies in both 
implant and positive control (MRL/MPJ) sections, but not in host tissue (Figure 4.6). 
Although there was some staining, those signals were not aligned with nuclei as observed 
in the cell sheet implant. Thus the cell sheets in our 3-sheet stacked implant can 
definitively integrate into a living host in a manner that allows it to both recruit new 
blood vessels and to grow. Cell sheets grown on muscle tissue native stiffness matching 
hydrogel substrates are robust, recapitulated native cell type phenotypic characteristics 
and rapidly integrate to the host tissue by recruiting blood vessels with angiogenesis. 
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4.4. Figures and Tables 
 
 
 
Figure 4.1 3-cell sheet in-vivo study; 3-cell sheet stack was inserted under the 
subcutaneous space of 3 months old female nude mice for 30 Days. On Day 25, incision 
scar was completely healed and no sign of inflammation was observed. A. Marked 
incision site. B. inserted cell sheet construct (white arrow) C-E. Implantation Day 5, 25, 
and 30 respectively  
 
 
D H C 
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Figure 4.2 Immunofluorescent detection of blood vessel (CD31/PECAM) on Day 30 
positive control and implant; Normal tissue at opposite dorsal flank was harvested to 
serve as a positive control A-B. positive control(10×, 60x) C-D. implant (10x, 60×) 
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Figure 4.3 Immunofluorescent staining on paraffin embedded section (7µm) to 
investigate possibility of vascularization by angiogenesis; harvested samples were 
embedded in paraffin blocks and with 7µm slices were taken. Isolectin and erythrocytes 
were targeted. Normal tissue in the contralateral dorsal flank was harvested to serve as a 
positive control. Scale bars are 50µm. A. Stained vessel lumen and erythrocytes in 
positive control (60x) B. Stained vessel lumen and erythrocytes in implants 60x C-D. 
Stained vessel lumen and erythrocytes in implant 10x and 60x White arrows point vessel 
lumen and red arrows point erythrocytes (red blood cells) 
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Figure 4.4 Immunofluorescent detection of the proliferation marker Ki-67 in 3-cell sheet 
implants after 30 days;. A-C. 20x view, D-F. 60x view of Ki-67, DAPI and merged image 
respectively. A-C, and D-F images taken from different samples. Scale bars are 50µm 
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Figure 4.5 Immunofluorescent detection of the C2C12 specific marker H-2Kk in 3-cell 
sheet implant after 30 days; A. H-2Kk and DAPI co-staining (implant) B. H-2Kk and 
DAPI co-staining (negative control) C. H-2Kk and DAPI co-staining (positive control). 
All scale bar are 50𝜇m 
 
 
 
 
4.5. Summary 
 
 In Aim 1, we demonstrated a stiffness-tunable hydrogel system that can be used 
to produce topographically patterned, stackable cell sheets characterized by high cell 
viability and pattern preservation after stacking. In Aim 2, we used the stiffness-tuning 
capabilities of this system to demonstrate that matching substrate stiffness to that of 
native tissue is an important determinant of myogenic differentiation in vitro. Finally in 
Aim 3, we used our hydrogel system to create a tri-level stack cell sheets and showed that 
this tissue construct can be successfully integrated into living host tissue. 
Immunohistochemical analysis of the integrated construct confirmed that cells within the 
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cell sheet implants proliferated and actively recruited blood vessels from the host. We 
conclude that our stiffness tunable hydrogel system allows the production of robust and 
phenotypically optimized cell sheets that can potentially be used as building blocks for 
numerous applications in tissue engineering. 
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Chapter 5. Conclusions  
The development of implantable, engineered tissues is an urgent unmet need in various 
medical fields. Conventional approaches have typically involved seeding cells in pre-
designed scaffolds made of synthetic or natural materials or in decellularized ECM. 
These approaches essentially force cells to adjust to a pre-determined mechanical and 
biochemical environment, leaving no freedom for the cell to control its own 
microenvironment. Moreover, the in vitro steps required for cell differentiation or ECM 
secretion in these models, which represents unnatural environments for cells, and has thus 
far not resulted in normal vascular homeostasis upon implantation. Indeed, a major 
problem associated with in vitro engineered tissues has been their propensity for 
generating thrombogenic responses upon implantation.  
Here, we have created a system in which cells in engineered tissues can have a 
full control to modify the environment according to their needs. Our novel cell sheet 
culture and transfer system based upon an enzymatically degradable versatile hydrogel 
platform is also highly practical because it does not compromise mammalian cell or ECM 
during the degradation process. This state-of-the-art system also has the capability to tune 
hydrogel substrate stiffness to match the stiffness of the native target tissue, which should 
lead to improved cell sheet performance in tissue-engineered constructs. Our cell sheet 
technology offers several additional advantages such as scalability for automated mass 
production, a cell friendly environment for the entire cell sheet culture and transfer 
procedure, and a high cell viability in the resulting cell sheets (>99%). Overall, this 
versatile system for generating cell sheets represents an important step forward in the 
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development of inexpensive, autologous engineered tissues that recapitulate native tissue 
properties to a high degree. 
 
FUTURE WORK 
We implanted red-fluorescent protein (RFP) labeled 3-cell sheet stack on July 29th, 2015 
for 30 day implantation. With this study, we could re-confirm that proliferating cell 
source is implanted cell sheet stack. We will inject FITC conjugated 150kDa dextran 
(Sigma Aldrich) to verify that the implant survived by systemic circulation. Furthermore, 
because we implanted muscle cells grown muscle stiffness matched substrate (10-13kPa), 
we will investigate gene and protein expression to confirm whether this is matching to in 
vitro results. We will also work on pre-vascularization of cell sheet stack to promote fast 
integration by inosculation 
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